Uterine cyclin A2–deficient mice as a model of female early pregnancy loss
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci163796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Fatimah Aljubran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Physiology. Hauptthemen laut MEDLINE: Cyclin A2, Mice, Knockout, Abortion, Spontaneous. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NICHD NIH HHS, NIH Kansas INBRE grant.
Abstract (Originalsprache)
Proper action of the female sex steroids 17β-estradiol (E2) and progesterone (P4) on the endometrium is essential for fertility. Beyond its role in regulating the cell cycle, cyclin A2 (CCNA2) also mediates E2 and P4 signaling in vitro, but a potential role in modulating steroid action for proper endometrial tissue development and function is unknown. To fill this gap in our knowledge, we examined human endometrial tissue from fertile and infertile cisgender women for CCNA2 expression and correlated this with pregnancy outcome. Functional assessment of CCNA2 was validated in vivo using a conditional Ccna2 uterine-deficient mouse model, while in vitro function was assessed using human cell culture models. We found that CCNA2 expression was significantly reduced in endometrial tissue, specifically the stromal cells, from women undergoing in vitro fertilization who failed to achieve pregnancy. Conditional deletion of Ccna2 from mouse uterine tissue resulted in an inability to achieve pregnancy, which appeared to be due to alterations in the process of decidualization, which was confirmed using in vitro models. From these studies, we conclude that CCNA2 expression during the proliferative/regenerative stage of the menstrual cycle allows for proper steroid responsiveness, decidualization, and pregnancy. When CCNA2 expression levels are insufficient, there is impaired endometrial responsiveness, aberrant decidualization, and loss of pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Physiology.
- Department of Obstetrics and Gynecology.
- Center for Reproductive Sciences.
- Department of Cancer Biology.
- Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, USA.
Förderung
- NIGMS NIH HHS
- NICHD NIH HHS
- NIH Kansas INBRE grant
- National Institutes of Health
Zitieren
APA
Aljubran, F., Schumacher, K., Graham, A., Gunewardena, S., Marsh, C., Lydic, M., Holoch, K., & Nothnick, W. B. (2024). Uterine cyclin A2–deficient mice as a model of female early pregnancy loss. Journal of Clinical Investigation. https://doi.org/10.1172/jci163796
Vancouver
Aljubran F, Schumacher K, Graham A, Gunewardena S, Marsh C, Lydic M, et al. Uterine cyclin A2–deficient mice as a model of female early pregnancy loss. Journal of Clinical Investigation. 2024. doi:10.1172/jci163796
BibTeX
@article{Aljubran2024,
author = {Aljubran, Fatimah and Schumacher, Katelyn and Graham, Amanda and Gunewardena, Sumedha and Marsh, Courtney and Lydic, Michael and Holoch, Kristin and Nothnick, Warren B},
title = {Uterine cyclin A2–deficient mice as a model of female early pregnancy loss},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci163796}
}
EUVIMED